Uses of Tahero

Tahero medicine has the effect of reducing fever and pain for children in cases of: dengue fever, cold, flu, teething, bacterial infection, viral infection after vaccination, after surgery,...
Tahero drug It is an effective pain reliever and fever reducer. Tahero acts on the thermoregulatory center in the hypothalamus causing hypothermia, increased thermogenesis due to vasodilation, and increased peripheral blood flow, reducing body temperature in febrile individuals. Paracetamol in the drug relieves pain by raising the pain threshold.
At therapeutic doses of Paracetamol, the analgesic and antipyretic effect is similar to Aspirin, but Paracetamol has little impact on the respiratory and cardiovascular systems, does not change the acid-base balance, does not cause scratches, irritation or bleeding. stomach.
Tahero is rapidly and almost completely absorbed from the gastrointestinal tract. The half-life of Tahero is 1.25 - 3 hours. Tahero is metabolised in the liver and eliminated by the kidneys.
Tahero drug is not used in the following cases:
Patients with hypersensitivity or history of allergy to Tahero drug and liver cell failure. Patients with anemia many times, have lung, kidney or liver disease, heart disease, G6PD enzyme deficiency.

Take Tahero pills each time at least 4-6 hours apart. In the event that after taking Tahero, there are no signs of fever or pain relief, the dose should not be increased and should consult a doctor.
Adults and children from 12 years old: Take 1 tube of 10ml Paracetamol/time x 2-3 times/day, not more than 6 ampoules/day. Children from 7-11 years old: Take 1/2 tube of Tahero / time x 2-3 times / day. Children under 5 years old: Tahero should not be used. . In case of overdose of Paracetamol: 7.5 - 10g of Paracetamol per day, for 1-2 days or by taking Tahero for a long time, overdose can cause liver necrosis and can lead to death. Typical manifestations are: nausea/vomiting, abdominal pain, mucous membranes and nails, cyanosis of the skin, mild irritation, agitation and delirium...
Patients need early diagnosis, which is very important in this case. Treatment of Tahero overdose requires active supportive treatment and gastric lavage in all cases, preferably within 4 hours of ingestion and administration of Sulfhydryl compounds. N - acetylcysteine ​​is effective when taking Tahero or intravenously. Alternatively, methionine or activated charcoal and/or salt bleach can be used.

Long-term intake of high doses of Tahero slightly increases the anticoagulant effect of Coumarin and Indandion derivatives. Tahero should be used with caution in patients receiving concomitant phenothiazines and hypothermia because of the potential for severe hypothermia. Anticonvulsants such as Barbiturates, Phenytoin, Carbamazepine, Isoniazid and anti-tuberculosis drugs combined with Tahero may increase the hepatotoxicity of Paracetamol. Excessive and long-term alcohol consumption can increase the risk of Tahero causing liver toxicity.

During the use of Tahero, patients may experience some unwanted side effects such as:
Skin rash Nausea, vomiting Kidney disease, kidney toxicity when using Tahero for a long time Decrease in neutrophils, decrease pancytopenia Anemia Hypersensitivity reactions. Patients need to inform the doctor about the unwanted effects encountered when using Tahero medicine.

For people with phenylketonuria - urine and people who have to limit the amount of phenylalanine put into the body should avoid taking Tahero with drugs or foods containing Aspartame. For some people with hypersensitivity (asthma) Tahero should be avoided with medicines or foods containing sulfites. Tahero should be used with caution in patients with pre-existing anemia, impaired liver and kidney function. Heavy drinking can increase Tahero's hepatotoxicity, so avoid or limit alcohol intake. The treating physician or pharmacist should warn the patient about the signs of a serious skin reaction when taking Tahero such as: toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), Lyell or acute generalized exanthematous pustulosis (AGEP). There are no accurate data on the safety of Paracetamol in the fetus when administered to pregnant women. Therefore, Tahero should be used in pregnancy only when clearly needed. In a study in nursing mothers, the use of Tahero did not show any undesirable effects in the nursing infant. Tahero does not affect the ability to drive and use machines.